Heublein et al. also performed immunohistochemistry to evaluate the expression of THRβ using anti-THRβ polyclonal antibodies (Table 2) in a patient cohort with BRCA1-associated (n = 38, 31%) and sporadic BC (n = 86, 69%). The gene discussed is THRB; the disease is breast cancer.